| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,174 | 0,193 | 09.01. |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | LIFETECH SCI (01302): VOLUNTARY ANNOUNCEMENT - G-ILIAC TM PRO ILIAC ARTERY STENT GRAFT SYSTEM OBTAINED OFFICIAL REGISTRATION APPROVAL FROM THE CHINA NMPA | 2 | HKEx | ||
| 09.12.25 | LIFETECH SCI (01302): CONNECTED TRANSACTION - SHARE PURCHASE PURSUANT TO SHARE AWARD SCHEME | 1 | HKEx | ||
| 21.11.25 | LIFETECH SCI (01302): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS | 3 | HKEx | ||
| 21.11.25 | LIFETECH SCI (01302): CHANGE OF DIRECTORS AND COMPOSITION OF BOARD COMMITTEES | 1 | HKEx | ||
| LIFETECH SCIENTIFIC Aktie jetzt für 0€ handeln | |||||
| 06.11.25 | LIFETECH SCI (01302): VOLUNTARY ANNOUNCEMENT - G-BRANCH TM THORACOABDOMINAL ARTERY STENT GRAFT SYSTEM OBTAINED OFFICIAL REGISTRATION APPROVAL FROM THE ... | - | HKEx | ||
| 29.10.25 | LIFETECH SCI (01302): VOLUNTARY ANNOUNCEMENT - PUBLICATION OF THE TWO-YEAR FOLLOW-UP RESULTS OF PHASE II CLINICAL STUDY AND PHASE III CLINICAL STUDY OF ... | - | HKEx | ||
| 10.09.25 | LIFETECH SCI (01302): NOTIFICATION LETTER AND REQUEST FORM FOR NON-REGISTERED SHAREHOLDERS | 1 | HKEx | ||
| 10.09.25 | LIFETECH SCI (01302): NOTIFICATION LETTER AND REPLY FORM FOR REGISTERED SHAREHOLDERS | 3 | HKEx | ||
| 10.09.25 | LIFETECH SCI (01302): INTERIM REPORT 2025 | 1 | HKEx | ||
| 29.08.25 | LifeTech Scientific Corporation reports 1H results | 1 | Seeking Alpha | ||
| 29.08.25 | LifeTech Scientific Corporation Announces 2025 Interim Results: Core Business Demonstrated Resilience, Domestic and Overseas Sales Both Increased | 170 | PR Newswire | HONG KONG, Aug. 29, 2025 /PRNewswire/ -- LifeTech Scientific Corporation ("LifeTech" or the "Company", together with its subsidiaries, the "Group", stock code:... ► Artikel lesen | |
| 29.08.25 | LIFETECH SCI (01302): INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2025 | 1 | HKEx | ||
| 22.08.25 | LIFETECH SCI (01302): VOLUNTARY ANNOUNCEMENT - ADMISSION OF INNOVATIVE MEDICAL DEVICES IN RESPECT OF CONGENITAL HEART DEFECT OCCLUDER INTO SPECIAL EXAMINATION ... | 2 | HKEx | ||
| 11.08.25 | LIFETECH SCI (01302): NOTICE OF BOARD MEETING | 1 | HKEx | ||
| 28.03.25 | LifeTech Scientific Corporation Announced 2024 Annual Results: Revenue Exceeded RMB1.3 billion, and International Business Increased by 26% | 251 | PR Newswire | SHENZHEN, China, March 28, 2025 /PRNewswire/ -- LifeTech Scientific Corporation (the "Company" or "LifeTech", Stock code: 1302.HK), a company specializing in... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 46,510 | -0,04 % | DEUTSCHE BANK RESEARCH stuft Siemens Healthineers auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Siemens Healthineers auf "Hold" mit einem Kursziel von 46 Euro belassen. Er rechne damit, dass der Start in das neue Geschäftsjahr... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,500 | +1,26 % | EQS-Adhoc: Fresenius Medical Care AG: Fresenius Medical Care AG setzt Aktienrückkaufprogramm beschleunigt fort | EQS-Ad-hoc: Fresenius Medical Care AG / Schlagwort(e): Aktienrückkauf
Fresenius Medical Care AG: Fresenius Medical Care AG setzt Aktienrückkaufprogramm beschleunigt fort
09.01.2026... ► Artikel lesen | |
| FRESENIUS | 49,230 | -1,05 % | dpa-AFX-Überblick: UNTERNEHMEN vom 09.01.2026 - 15.15 Uhr | ROUNDUP: Teamviewer erreicht Umsatzziel für 2025 - Aktie mit Erholungsversuch GÖPPINGEN - Der Softwareanbieter Teamviewer hat 2025 sein im Herbst gesenktes Umsatzziel knapp erreicht. Basierend auf... ► Artikel lesen | |
| BETA BIONICS | 20,550 | -35,76 % | Beta Bionics, Inc.: Beta Bionics Announces Preliminary, Unaudited Fourth Quarter 2025 Topline Financial Results and Key Metrics | IRVINE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its preliminary... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 37,620 | -3,74 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 41,260 | -1,01 % | EQS-PVR: Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Carl Zeiss Meditec AG
Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the... ► Artikel lesen | |
| PROGYNY | 26,990 | -1,64 % | Progyny-Aktie: Truist Securities stuft auf 'Kaufen' hoch und verweist auf verbesserte Aussichten | ||
| GERRESHEIMER | 27,400 | +0,37 % | Gerresheimer AG: Die Klarheit in der Rechnungslegung verbessert sich, aber die Vertrauenslücke bleibt bestehen. HALTEN. | Gerresheimer (GXI) hat das Kapitel der Bill-and-Hold-Buchhaltung abgeschlossen, indem etwa 28 Millionen EUR an Umsätzen für das Geschäftsjahr 2024 vollständig korrigiert wurden, nachdem eine von der... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 20,755 | -0,93 % | Where Alignment Healthcare Stands With Analysts | ||
| CLEARPOINT NEURO | 14,950 | -2,35 % | ClearPoint Neuro schließt Zustimmungsvereinbarung zur Restrukturierung von IRRAS AB | ||
| GENEDX | 135,54 | -1,32 % | GeneDx partners with Komodo Health to create comprehensive rare disease dataset | ||
| PROCEPT BIOROBOTICS | 32,840 | -4,76 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| LUMEXA IMAGING | 16,840 | -5,02 % | Lumexa Imaging Draws Bullish Analyst Calls On Heels Of IPO | ||
| INTELLIGENT BIO SOLUTIONS | 18,055 | +24,43 % | INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report | ||
| HEARTFLOW | 33,200 | -0,81 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen |